美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Galena Biopharma

0.2620

0.0000

成交量：- -

成交額：- -

市值：1,006.21萬

市盈率：-0.11

高：0.2620

開：0.2620

低：0.2620

收：0.2620

52周最高：2.41

52周最低：0.2568

股本：3,840.50萬

流通股本：937.02萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.2900

淨資產收益率：--

總資產收益率：--

市淨率：0.53

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Galena Biopharma

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.galenabiopharma.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Galena Biopharma, Inc.在美國特拉華州於2006年4月3日成立作為淘金製藥公司，並2006年11月28日更名為瑞克斯的製藥公司。2011年9月26日，公司把名稱改為格拉納生物製藥有限公司。格拉納是一家生物技術公司，致力於發現，開發和商業化創新療法來滿足使用有針對性的生物療法的主要醫療需求。格拉納是追求用肽為基礎的免疫療法產品的新的癌症治療學的發展，包括其主要的候選產品肽類（E75）用於治療乳腺癌和其他腫瘤。在低到中等HER2陽性乳腺癌患者不符合曲妥珠單抗里，肽類藥物是一種肽為基礎的免疫療法旨在降低乳腺癌的複發率。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GALE/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GALE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GALE\",,,,,undefined,":{"symbol":"GALE","market":"US","secType":"STK","nameCN":"Galena Biopharma","latestPrice":0.262,"timestamp":1514581200000,"preClose":0.262,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":9370232,"shares":38405000,"eps":-2.29,"marketStatus":"退市","change":0,"latestTime":"12-29 16:00:00 EST","open":0.262,"high":0.262,"low":0.262,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.29,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.262,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GALE\",,,,,undefined,":{"symbol":"GALE","floatShares":9370232,"roa":"--","roe":"--","lyrEps":0,"shares":38405000,"dividePrice":0,"high":0.262,"amplitude":0,"preClose":0.262,"low":0.262,"week52Low":0.2568,"pbRate":"0.53","week52High":2.41,"institutionHeld":0,"latestPrice":0.262,"eps":-2.29,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.29,"open":0.262},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GALE\",params:#limit:5,,,undefined,":[{"date":"2018-01-02","symbol":"GALE","type":"split","dateTimestamp":1514869200000,"forFactor":30,"toFactor":1},{"date":"2018-01-02","symbol":"GALE","newSymbol":"SLS","type":"symbolChange","dateTimestamp":1514869200000},{"market":"US","date":"2017-11-09","symbol":"GALE","fiscalQuarterEnding":"2017/09","expectedEps":-0.15,"name":null,"time":"","type":"earning","dateTimestamp":1510203600000,"reportTimeType":"","actualEps":-0.15},{"market":"US","date":"2017-08-14","symbol":"GALE","fiscalQuarterEnding":"2017/06","expectedEps":-0.15,"name":null,"time":"盤後","type":"earning","dateTimestamp":1502683200000,"reportTimeType":"post","actualEps":-0.16},{"market":"US","date":"2017-05-10","symbol":"GALE","fiscalQuarterEnding":"2017/03","expectedEps":-0.22,"name":null,"time":"","type":"earning","dateTimestamp":1494388800000,"reportTimeType":"","actualEps":-0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GALE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GALE\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.galenabiopharma.com","stockEarnings":[{"period":"1week","weight":-0.9667},{"period":"1month","weight":-0.9667},{"period":"3month","weight":-0.9667},{"period":"6month","weight":-0.9667},{"period":"1year","weight":-0.9667},{"period":"ytd","weight":-0.9667}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Galena Biopharma, Inc.在美國特拉華州於2006年4月3日成立作為淘金製藥公司，並2006年11月28日更名為瑞克斯的製藥公司。2011年9月26日，公司把名稱改為格拉納生物製藥有限公司。格拉納是一家生物技術公司，致力於發現，開發和商業化創新療法來滿足使用有針對性的生物療法的主要醫療需求。格拉納是追求用肽為基礎的免疫療法產品的新的癌症治療學的發展，包括其主要的候選產品肽類（E75）用於治療乳腺癌和其他腫瘤。在低到中等HER2陽性乳腺癌患者不符合曲妥珠單抗里，肽類藥物是一種肽為基礎的免疫療法旨在降低乳腺癌的複發率。","exchange":"NASDAQ","name":"Galena Biopharma","nameEN":"Galena Biopharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GALE\",market:\"US\",,,undefined,":null}}